ADM LIPOSOME THERAPY IN THE TREATMENT OF FORTY FIVE PATIENTS WITH ADVANCED LIVER CANCER / 肿瘤研究与临床
Cancer Research and Clinic
; (6)2000.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-674728
Biblioteca responsável:
WPRO
ABSTRACT
Objective:
To compare the survival rate and side effects of doxorubic in (ADM) liposome therapy and ADM therapy for liver cancer.Methods:
87 patients with advanced liver cancer were divided into two groupsGroup A was treated by ADM liposome chemotherapy and group B by ADM chemotherapy.Results:
The mean survival and 1 year survival rates showed no obvious difference in both groups.However,patients in Group A showed better immediate curative effect and lower immediate side effects than Group B.Conclusion:
ADM Liposome chemotherapy increase the immediate curative effects and decrease the general reactions.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Cancer Research and Clinic
Ano de publicação:
2000
Tipo de documento:
Artigo